期刊文献+

硫酸氢氯吡格雷联合阿司匹林抗血小板治疗不稳定型心绞痛60例临床分析 被引量:19

下载PDF
导出
摘要 目的分析硫酸氢氯吡格雷联合阿司匹林抗血小板治疗不稳定型心绞痛(UAP)临床疗效。方法资料完整住院患者60例,分为冠心病常规治疗组(对照组)和常规治疗上加用小剂量氯吡格雷组(治疗组),分析两组疗效和副作用。结果治疗组显效20例,有效8例,无效2例,总有效率93.3%;对照组显效14例,有效8例,无效8例,总有效率73.3%,两组总效率比较差异有统计学意义(χ2=9.8,P<0.01)。结论氯吡格雷联合阿司匹林"二联"强化抗血小板治疗UAP,比单用阿司匹林抗栓治疗具有更好的临床效果,未见出血的危险。
作者 钱福东
出处 《安徽医学》 2010年第6期659-660,共2页 Anhui Medical Journal
  • 相关文献

参考文献6

二级参考文献22

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 2柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2143
  • 3Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿(译),David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志(中文版),2007,26(3):131-139. 被引量:59
  • 4Fragnfin during Instability in Coronary Artery Disease (FRISC) study group. Low-molecular-weight heparin during instability in coronary artery disease. Lancet, 1996,347:561-568.
  • 5Klein W, Buchwald A, Hillis SE, et al. Comparison of low- molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC) . Circulation, 1997,96:61-68.
  • 6Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfraetionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction : FRAX. I.S. ( FRAxiparine in Ischaemic Syndrome). Eur Heart J, 1999,20 : 1553-1562.
  • 7Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low- molecular-weight heparin with unfract/onated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med, 1997,337:447-452.
  • 8Antman EM, McCabe CH, Gurfinkel EP, et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/ non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) llB trial. Circulation, 1999,100: 1593-1601.
  • 9FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC Ⅱ prospective randomised multicentre study. Lancet, 1999,354:708- 715.
  • 10Wallentin L, Bergstrand L, Dellborg M, et al. Low molecular weight heparin (dalteparin) compared to unfractionated heparin as an adjunct to rt-PA (alteplase) for improvement of coronary artery patency in acute myocardial infarction-the ASSENT Plus study. Eur Heart J, 2003,24:897-908.

共引文献2733

同被引文献106

引证文献19

二级引证文献128

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部